APA (7th ed.) Citation

Grode, L., Ganoza, C. A., Brohm, C., Weiner, J., Eisele, B., & Kaufmann, S. H. (2013). Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine, 31(9), 1340-1348. https://doi.org/10.1016/j.vaccine.2012.12.053

Chicago Style (17th ed.) Citation

Grode, Leander, Christian A. Ganoza, Christiane Brohm, January Weiner, Bernd Eisele, and Stefan H.E Kaufmann. "Safety and Immunogenicity of the Recombinant BCG Vaccine VPM1002 in a Phase 1 Open-label Randomized Clinical Trial." Vaccine 31, no. 9 (2013): 1340-1348. https://doi.org/10.1016/j.vaccine.2012.12.053.

MLA (9th ed.) Citation

Grode, Leander, et al. "Safety and Immunogenicity of the Recombinant BCG Vaccine VPM1002 in a Phase 1 Open-label Randomized Clinical Trial." Vaccine, vol. 31, no. 9, 2013, pp. 1340-1348, https://doi.org/10.1016/j.vaccine.2012.12.053.